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. Figure 1D ). The patient's first-degree relatives did not consent to clinical or genetic testing, precluding segregation analysis. To exclude the possibility that the Thr1547Ile substitution was a polymorphism in the general population, 4,000 chromosomes in 2,000 unrelated, healthy and predominantly white individuals were tested by heteroduplex analysis. 4 All samples scanned were negative for the 4640C>T defect in exon 38, implicating the genetic anomaly as a pathogenic mutation.
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To determine the consequences of the patient's Thr1547Ile mutation on channel structure, the regulatory SUR2A subunit of the K ATP channel was compared with its orthologs and isoforms. Protein alignments revealed that the missense substitution altered the amino acid sequence of the evolutionarily conserved carboxy-terminal tail ( Figure 1E ). Homology modeling 4 mapped the defect adjacent to the signature Walker motifs of the nucleotide binding domain, required for coordination of adenine nucleotides in the nucleotide binding pocket ( Figure 1F ). 5 The carboxy-terminal tail, including the Thr1547 residue, is structurally and functionally unique, distinguishing the SUR2A isoform from noncardiac SUR proteins ( Figure 1G ). 5 Removal of the polar threonine (Thr1547) and replacement with the larger aliphatic and highly hydrophobic isoleucine, as would occur in this patient, predicted compromised nucleotide-dependent K ATP channel gating (Figure 2A) .
To replicate the disease mutation and assess the effects of altered K ATP channel structure on function, recombinant constructs of channel genes were expressed in cultured cells. 4 Patch-clamp recording demonstrated that the Thr1547Ile substitution compromised adenine nucleotide-dependent induction of K ATP channel current ( Figure 2B ). Mutant Thr1547Ile SUR2A, coexpressed with the KCNJII-encoded Kir6.2 pore, generated an aberrant channel that retained ATP-induced inhibition of potassium current, but demonstrated a blunted response to ADP ( Figure 2B-D) . A deficit in nucleotide gating, resulting from the Thr1547Ile mutation, would compromise the homeostatic role of the K ATP channel required for proper readout of cellular distress and maintenance of electrical stability ( Figure 2E ). The pathogenic link between channel malfunction and adrenergic AF was verified, at the whole organism level, in a murine knockout model deprived of operational K ATP channels. 3 Compared with the normal atrium, resistant to arrhythmia under adrenergic provocation, vulnerability to AF was recapitulated in the setting of a K ATP channel deficit ( Figure 2F ,G). Thus a lack of intact K ATP channels, either because of a naturally occurring mutation affecting channel regulation or targeted disruption of the channel complex, is a substrate for atrial electrical instability under stress, and a previously unrecognized molecular risk factor for adrenergic AF.
Failure of medical therapy, with refractoriness or intolerance to antiarrhythmic medication, was an indication for ablative intervention to restore sinus rhythm in the patient. Following mapping of the earliest activation sites for AF within the left atrium, radiofrequency energy was delivered to achieve electrical isolation of the initiating source ( Figure 3A ,B). Following ablation of the right superior pulmonary vein orifice, ectopy-initiating AF persisted, and was eliminated only after electrical isolation of the vein of Marshall ( Figure 3B ). In fact, once the vein of Marshall had been isolated, AF could no longer be provoked by programmed electrical stimulation and burst pacing with or without isoproterenol infusion ( Figure 3B ). Following ablation, the patient has remained in sinus rhythm and symptom-free over a 2.5 year follow-up period.
DISCUSSION OF DIAGNOSIS
AF is an electrical disorder characterized by chaotic atrial activation, defined on the electrocardiogram as replacement of sinus P waves by rapid oscillations or fibrillatory waves associated with an irregular ventricular response. A growing epidemic in the aging population with structural heart disease, AF also presents as an earlier-onset, apparently idiopathic, condition in a subset of patients 6 and is increasingly recognized as a heritable disorder. 7 The paradigm of a genetic basis for AF is exemplified by reports of familial disease attributed to gain-of-function 8 or lossof-function 1 mutations in ion channel genes predicted to accelerate or slow repolarization. In these cases, channel malfunction creates an arrhythmogenic milieu of re-entry or triggered activity caused by reduced electrical refractoriness or after-depolarization, respectively. 1, 8 AF is thus emerging as an inherited channelopathy, 1, 7, 8 although the molecular basis for this arrhythmia in the majority of patients remains undefined.
In this case of early-onset lone AF, the medical history and the diagnostic electro physiological study established a lack of traditional risk factors, but a vulnerability to adrenergic stress-a known trigger of arrhythmogenesis. 9 Electroanatomical interrogation localized the initiating arrhythmogenic trigger to a veno-atrial interface. Premature atrial ectopy that increased in the presence of isoproterenol was mapped to the vein of Marshall. This vestige of the embryonic left superior vena cava, rich in sympathetic innervation, is a recognized catecholamine-sensitive focus of atrial ectopy. 10 Although this potentially arrhythmogenic veno-atrial interface is present in the population at large, it does not trigger arrhythmia in the majority of individuals. 11 In certain patients, vulnerability to adrenergic AF in the absence of structural heart disease, as in this case, implicates an inherent defect in electrical stability. Why certain patients develop veinof-Marshall-triggered AF while others do not, despite comparable environmental stress exposure, might ultimately depend on their genetic make-up.
While family history did not specifically point to a genetic defect in this patient, the apparent lack of AF among first-degree relatives did not preclude molecular genetic investigation, as a de novo or incompletely penetrant mutation could account for a negative family history. Selection of K ATP channels for mutation screening was based on the unique property of these metabolism-sensing channels to operate as molecular stress-responsive rheostats .
2 The K ATP channel is formed by the regulatory SUR2A subunit, which harbors nucleotide binding domains, and Kir6.2, the conduit for potassium ions. 12 Under increased cardiac workload, build-up of intracellular ADP at SUR2A translates into channel opening and action potential shortening, limiting calcium overload induced by adrenergic stimulation. 2, 3 Gene expression and electrophysiological studies in patients with AF have demonstrated altered atrial ion channel mRNA transcription and post-translational activity, including downregulation of the K ATP channel pore and associated current. 13, 14 Moreover, genetic deficits in K ATP channels have recently been linked to myopathic heart disease and electrical instability. 4 In fact, deficient repolarization reserve under K ATP channel malfunction predisposes to early after-depolarization and the induction of triggered activity under sympathetic stress. 15 Upon identification of an ABCC9 sequence variant in the patient's genomic DNA, a comprehensive algorithm was implemented. Initial genetic screening for the variant in a control population was followed by in silico protein modeling, verification of mutant channel malfunction by patch-clamp electrophysiology, and linkage to disease susceptibility through gene targeting. This individualized approach enabled the molecular diagnosis of K ATP channel dysfunction to be established.
DIFFERENTIAL DIAGNOSIS
Recurrent palpitations in a young person with a structurally normal heart could be attributable to supraventricular arrhythmia involving accessory pathways, atrioventricular node re-entry tachycardia, or atrial tachycardia, all of which were excluded in this patient by surface electrocardiography and invasive electrophysiology. Catecholamine-sensitive early-onset arrhythmias can also originate in the ventricle, as is the case with right ventricular outflow tract tachycardia, catecholaminergic polymorphic ventricular tachycardia, and arrhythmogenic right ventricular myopathy. These conditions were excluded by cardiac imaging, electrocardiography and invasive electrophysiology, which demonstrated that electrical activation originated in the vein of Marshall. A subset of patients with an apparently idiopathic form of AF could have an underlying cardiac channelopathy. Lone AF has been linked to mutations in genes encoding voltage-gated or inwardly-rectifying potassium channels, 1, 7, 8 yet in this case genetic and functional tests uncovered a defect in the ATP/ADP-gated SUR2A subunit, indicating a K ATP channelopathy.
TREATMENT AND MANAGEMENT
AF in this patient was refractory to medical therapy with sodium and potassium channel inhibitors, and anti-adrenergic therapy was poorly tolerated owing to adverse effects. Currently, K ATP channel opening drugs are not approved for the treatment of rhythm disorders. The apparently curative outcome following ablation of the vein of Marshall in this patient would indicate that vulnerability to arrhythmia was caused by a combination of localized susceptibility to adrenergic stress, and an inability of mutant K ATP channels to safeguard against catecholamineinduced ectopy ( Figure 3C Postablation: despite isoproterenol infusion (2 μg/min), the vein of Marshall potential or ectopy could no longer be induced and the patient remained in sinus rhythm. (C) Adrenergic challenge provoked ectopy from the vein of Marshall, triggering transition from sinus rhythm to AF in the susceptible patient with inadequate adaptation to imposed stress load. As stress-responsive K ATP channels preserve electrical homeostasis, channel malfunction resulting from gene mutation creates a risk-conferring substrate, predisposing to arrhythmia. Ablation of the arrhythmia-triggering source disrupted the arrhythmogenic gene-environment interaction. Abbreviations: ABL d, distal electrodes of ablation catheter; ABL p, proximal electrodes of ablation catheter; AF, atrial fibrillation; CS, coronary sinus catheter (distal, proximal); HIS, His bundle recording catheter; HRA, high right atrial catheter; LS, left superior pulmonary vein catheter (distal, proximal); Map, mapping catheter; RVA, right ventricular apex catheter; SR, sinus rhythm; V1, surface electrocardiogram.
highly symptomatic patients with AF refractory to medical therapy, yet no randomized clinical trial comparing pharmacotherapy to ablation has yet been conducted. AF did not recur despite persistence of genetically defective K ATP channels. This result indicates that elimination of the arrhythmogenic source-prone to catecholamine-induced electrical instability 10 disrupted the arrhythmogenic gene-environment interaction, and was sufficient to overcome the inherent intolerance at the vein of Marshall to ongoing adrenergic stress ( Figure 3C ). This outcome is in line with successful treatment of ventricular fibrillation in genetic arrhythmia syndromes by ablation of triggers from the Purkinje conducting system arborization or the right ventricular outflow tract. 16 Notwithstanding, defective K ATP channels remain throughout the patient's atrial myo cardium despite focal ablation, and adrenergic AF might recur with advancing age and cumulative risk load despite electrical isolation of the vein of Marshall. While gene therapy and pharmacotherapy are not currently applicable for targeted rescue of mutated channels, recurrence of AF in this K ATP channelopathy could be responsive to reduction of upstream adrenergic burden (by β-adrenergic blockade or permanent pacing) or of downstream calcium overload (by calcium channel blockade). 3 
CONCLUSION
We identified a genetic defect in the homeostatic K ATP channel of a patient with a structurally normal heart and a catecholamine-sensitive vein of Marshall trigger for AF, uncovering a molecular basis for impaired atrial stress responsiveness and susceptibility to early-onset disease. Discovery of the ABCC9 mutation represents the first known instance of a genetic defect in adrenergic, focal AF. This case thus defines K ATP channel dysfunction as a substrate for atrial arrhythmia triggered by environmental stress (Figure 3C ), and establishes a novel K ATP channelopathy 17 in human disease. Subsequent targeted screening for the Thr1547Ile SUR2A mutation in patients (n = 154) with diverse presentations of AF indicate that this specific genetic substitution is not common. Future research will be required to determine the overall mutation frequency within K ATP channel genes and the spectrum of genotype-phenotype relationships. While the case underscores heritable channel dysfunction in lone AF, K ATP channel deficit could play a broader role in the pathogenesis of electrical instability. Metabolic 2 and mechanosensitive 18 gating of K ATP channels might indeed become compromised with structural heart disease and atrial dilation, precipitating suboptimal repolarization reserve and providing a substrate for the more common acquired form of AF.
